Novartis AG (NYSE: NVS)

http://www.novartis.com

Twitter: @Novartis

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2015, the Group achieved net sales of USD 49.4 billion, while R&D throughout the Group amounted to approximately USD 8.9 billion (USD 8.7 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 119,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world. *

	Start	1996-12-20 merged
	Group	Novartis (Group)
	Industry	LIFE SCIENCES
	Person	Narasimhan, Vasant (Vas) (Novartis 201408– Global Head Developm Novartis Pharma before Global Head Developm Vaccines
	Person 2	Reinhardt, Jörg (Novartis 201308– Board Chairman before Bayer 201008– CEO Bayer HealthCare AG before Novartis COO)

	Region	Basel BS
	Country	Switzerland
	City	4002 Basel BS
	Tel	41 61 324 8000
		Address record changed: 2018-07-24

Basic data	Employees	J: more than 100,0 (2018-12-31)
	Currency	USD
	Annual sales	47,498,000,000 (sales, net, continued operations, consolidated (2019) 2019-12-31)
	Profit	7,147,000,000 (2019-12-31)
	Cash	11,112,000,000 (2019-12-31)

		* Document for ï¿½About Sectionï¿½: Novartis AG. (1/27/16). "Press Release: Novartis Delivered Strong Sales Growth and Core Margin Expansion (cc[1]) in 2015, Announces Plans to Accelerate Growth at Alcon, Streamline Group Operations". Basel.

		Record changed: 2020-09-07